Ustekinumab Clinical Trials
13 recruitingDrug
Phase 24Phase 43Phase 12Phase 32
Showing 1–13 of 13 trials
Recruiting
Phase 3
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Plaque Psoriasis
Bristol-Myers Squibb3,040 enrolled350 locationsNCT07116967
Recruiting
Phase 1Phase 2
An Open-Label, Proof of Consent Study of Vorinostat for the Treatment of Mdoerate-to-Severe Crohn s Disease and Maintenance Therapy With Ustekinumab
Crohn's Disease
National Institute of Allergy and Infectious Diseases (NIAID)35 enrolled1 locationNCT03167437
Recruiting
Phase 4
Development of Predictive Psoriasis Response Endotypes Using Single Cell Transcriptomics
Psoriasis
University Hospitals Cleveland Medical Center56 enrolled1 locationNCT05270733
Recruiting
Phase 4
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
Crohn's Disease
Takeda100 enrolled54 locationsNCT06045754
Recruiting
A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease and Ulcerative Colitis
Crohn Disease
Janssen Scientific Affairs, LLC1,056 enrolled1 locationNCT04372108
Recruiting
Phase 2
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
Cancer
M.D. Anderson Cancer Center10 enrolled1 locationNCT06807593
Recruiting
Efficacy of Ustekinumab Therapy in Patients With Symptomatic Stricturing Crohn's Disease
Crohn DiseaseStricture; BowelIntestinal Stricture
Second Affiliated Hospital, School of Medicine, Zhejiang University239 enrolled8 locationsNCT05387031
Recruiting
Phase 4
Efficacy and Safety of Dual-targeted Therapy With Upadacitinib and Ustekinumab Versus Intensified Ustekinumab Therapy in Crohn's Disease
Crohn Disease
Sixth Affiliated Hospital, Sun Yat-sen University214 enrolled1 locationNCT06520397
Recruiting
Phase 2Phase 3
Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation
Skin InflammationAllergic Contact Dermatitis
Wei-Che Ko45 enrolled1 locationNCT05535738
Recruiting
Phase 2
Comparison of Ustekinumab, Infliximab and Combination Therapy in Moderately to Severely Active Ulcerative Colitis
Inflammatory Bowel DiseasesUlcerative Colitis
Medical University of Lodz172 enrolled1 locationNCT06453317
Recruiting
Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
PregnancyCrohn DiseasePsoriasis+1 more
University of California, San Diego200 enrolled1 locationNCT02103361
Recruiting
Phase 1
Quantitative Fluorescence Molecular Imaging of Ustekinumab-800CW to Elucidate the Drug Distribution Throughout Inflamed Tissue in Crohn's Disease and Psoriasis.
Crohn DiseasePsoriasis
University Medical Center Groningen56 enrolled1 locationNCT05725876
Recruiting
Swiss Dermatology Network of Targeted Therapies (SDNTT)
Psoriasis
Swiss Dermatology Network for Targeted Therapies1,121 enrolled6 locationsNCT01706692